• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

scPharmaceuticals Inc. - Common Stock (NQ:SCPH)

5.670 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about scPharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
SCPH Stock Earnings: scPharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗
May 14, 2024
SCPH stock results show that scPharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
April 05, 2024
 
Via Benzinga
News headline image
Recap: scPharmaceuticals Q4 Earnings ↗
March 13, 2024
 
Via Benzinga
News headline image
A Preview Of scPharmaceuticals's Earnings ↗
March 12, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
January 22, 2024
 
Via Benzinga
News headline image
Recap: scPharmaceuticals Q3 Earnings ↗
November 08, 2023
 
Via Benzinga
News headline image
Earnings Preview: scPharmaceuticals ↗
November 07, 2023
 
Via Benzinga
News headline image
Earnings Outlook For scPharmaceuticals ↗
August 09, 2023
 
Via Benzinga
News headline image
The Latest Analyst Ratings for scPharmaceuticals ↗
July 19, 2023
 
Via Benzinga
News headline image
Analyst Ratings for scPharmaceuticals ↗
June 08, 2023
 
Via Benzinga
News headline image
Earnings Scheduled For March 13, 2024 ↗
March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. 
Via Benzinga
News headline image
Dow Up 150 Points; Gold Jumps Over 2% ↗
March 23, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Thursday. The Dow traded up 0.47% to 32,180.26 while the NASDAQ rose 1.29% to 11,820.77. The S&P... 
Via Benzinga
News headline image
Earnings Preview For scPharmaceuticals ↗
March 21, 2023
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About scPharmaceuticals ↗
January 27, 2023
 
Via Benzinga
Expert Ratings for scPharmaceuticals ↗
December 01, 2022
 
Via Benzinga
5 Analysts Have This to Say About scPharmaceuticals ↗
December 01, 2022
 
Via Benzinga
News headline image
Analyst Ratings for scPharmaceuticals ↗
November 10, 2022
Within the last quarter, scPharmaceuticals (NASDAQ:SCPH) has observed the following analyst ratings: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023 ↗
September 07, 2023
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
March 23, 2023
 
Via Benzinga
News headline image
Earnings Scheduled For August 10, 2023 ↗
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
News headline image
Earnings Outlook For scPharmaceuticals ↗
May 09, 2023
 
Via Benzinga
News headline image
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
March 23, 2023
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023. 
Via Benzinga
News headline image
Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs ↗
March 23, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.42% to 32,484.03 while the NASDAQ rose 2.40% to 11,949.60. The S&P 500,... 
Via Benzinga
News headline image
KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday ↗
March 23, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
February 27, 2023
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
February 17, 2023
 
Via Benzinga
News headline image
$5 Million Bet On Lifecore Biomedical? Check Out These 4 Stocks Insiders Are Buying ↗
November 30, 2022
Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 ↗
December 01, 2022
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
November 22, 2022
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session ↗
November 21, 2022
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap